Press "Enter" to skip to content

U.S. drug developer Capricor places Duchenne drug trial on hold

The review follows a severe allergic reaction during infusion of the drug, the company said in a filing. The patient responded well to medical treatment and is currently asymptomatic.

Original source: https://health.economictimes.indiatimes.com/news/pharma/u-s-drug-developer-capricor-places-duchenne-drug-trial-on-hold/67257855?utm_source=RSS&utm_medium=ETRSS

Also Read:   Apellis' drug better than Soliris in improving hemoglobin levels in trial